|

|
| Mr. Ravi Prasad (right), CEO, Himalaya Healthcare,
and Dr. S.K. Mitra, Executive Director, Research & Technical
Services, at the launch of 'Chyavanaprasha' in Mumbai on Tuesday.
|
The Himalaya Drug Company expects to double its turnover in the
next two years. The herbal healthcare company is expected to end
the financial year 2002-03 with a sales figure of Rs. 325 crore
as compared with Rs. 250 crore last fiscal.
Speaking to newspersons in Mumbai, Mr. Ravi Prasad, President and
Chief Executive Officer. The Himalaya Drug Company said the company
expected a tremendous boost in its sales figures through new product
launches. "We expect to hit Rs. 500 crore in the year 2005
through new product launches", he said.
The company's overseas operations are also expected to contribute
increasingly. "The international markets for herbal products
is showing remarkably high growth rates. Overseas operations contribute
about 20 per cent to the overall turnover and this is set to increase
substantially this year", Mr. Prasad said. The company has a
presence in 55 countries.
Himalaya recently made an entry into the Rs. 400 crore Chyavanaprasha
segment by launching a 500 gm jar priced at Rs. 110. The company
targets Rs. 20-crore sales in the first year itself.
The personal care range formerly under the brand name 'Ayurvedic
Concepts' is also expected to contribute significantly to the turnover.
According to Mr. Prasad, the division will register an over Rs.
50 crore sales figure this year. "The personal care range has
done extremely well in the past five years registering a phenomenal
100 per cent growth in terms of sales. This year, we expect the
growth rate to be about 85 per cent". He added. The company
is set to increase its dedicated Himalaya Drug outlets from 18 to
50 this year.
|